Expression of vascular endothelial growth factor in follicular cell-derived lesions of the thyroid: Is NIFTP benign or precancerous?

Neslihan Kurtulmuş, Fatma Tokat, Mete Düren, Hakan Kaya, Burak Ertaş, Ümit İnce

2022, Volume 38, Issue 1 Pages: 060-066 DOI: 10.47717/turkjsurg.2022.5318

What has changed in the last 20 years in the postoperative specimen findings of the papillary thyroid cancer cases? A retrospective analysis

Burak Bakar, Pınar Taşar, Turkay Kırdak, Sadık Kılıçturgay

2022, Volume 38, Issue 4 Pages: 345-352 DOI: 10.47717/turkjsurg.2022.5688

Radiofrequency ablation of metastatic lymph nodes in a patient requiring secondary operation for papillary thyroid carcinoma metastasis

Gizem Öner, Beyza Özçınar, Orhan Ağcaoğlu, Nihat Aksakal, Artur Salmaslıoğlu, Cem Yücel, Yeşim Erbil

Ahead of Print DOI: 10.47717/turkjsurg.2023.4631

The effect of different therapeutic treatments on the frequency of postoperative hypocalcemia in patients with thyroidectomy

Hamdi Burak Piyade, Mahmut Başoğlu, Ersan Gürsoy

2023, Volume 39, Issue 1 Pages: 070-075 DOI: 10.47717/turkjsurg.2023.5886

A rare location of papillary carcinoma: Thyroglossal duct cyst

Mehmet Haciyanlı, Selda Gücek Haciyanlı, Serkan Karaisli, Tuba Balkaya, Turan Acar, Erdinç Kamer

2023, Volume 39, Issue 1 Pages: 083-085 DOI: 10.47717/turkjsurg.2022.4268

How good is lobectomy for the Turkish population with papillary thyroid cancer? A clinicopathological evaluation

Can Konca

2023, Volume 39, Issue 3 Pages: 249-257 DOI: 10.47717/turkjsurg.2023.6210

Journal Metrics

  2020 2021 2022
SCImago Journal Rank 0.216 0.180 0.218
CiteScore (Scopus) 1.0 1.1 1.1
CiteScore Rank (Scopus) #279/422 #291/469 #312/495
Journal Citation Indicator (Clarivate) 234/271 (Q4) 227/279 (Q4) 230/286 (Q4)



Open Access